Division of General Surgery, McMaster University, Hamilton, Canada.
McMaster Pediatric Surgery Research Collaborative, McMaster University, Hamilton, Canada; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Canada.
J Pediatr Surg. 2024 May;59(5):863-868. doi: 10.1016/j.jpedsurg.2024.01.045. Epub 2024 Feb 3.
Enteral feeding is an essential part of the management of infants with gastroschisis. We hypothesized that exclusive breast milk is associated with improved neonatal outcomes.
We conducted a retrospective review of infants with uncomplicated gastroschisis through the Canadian Pediatric Surgery Network (CAPSNet) and Canadian Neonatal Network (CNN). The primary outcome was time to full enteral feeds.
We identified 411 infants with gastroschisis treated at CAPSNet centres from 2014 to 2022. 144 patients were excluded due to gestational age <32 weeks, birth weight <1500 g, other congenital anomalies, or complicated gastroschisis. Of the remaining 267 participants, 78% (n = 209) received exclusive breast milk diet in the first 28 days of life, whereas 22% (n = 58) received supplemental or exclusive formula. Infants who received exclusive breast milk experienced higher time to reach full enteral feeding (median 24 vs 22 days, p = 0.047) but were more likely to have undergone delayed abdominal closure (32% vs 17%, p = 0.03). After adjustment, there were no significant differences between groups in time to reach full enteral feeds, duration of parenteral nutrition, or length of stay. Infants who received supplemental or exclusive formula had a similar risk of necrotizing enterocolitis (4% vs 3%) but were less likely to transition to exclusive breast milk at discharge (73% vs 11%, p < 0.001).
Early use of exclusive breast milk in infants with uncomplicated gastroschisis is associated with similar outcomes compared to supplemental or exclusive formula. Patients who received supplemental or exclusive formula were unlikely to transition to exclusive breastfeeding by discharge.
Level IIb (Individual Cohort Study).
肠内喂养是治疗先天性腹壁裂患儿的重要组成部分。我们假设纯母乳喂养与改善新生儿结局相关。
我们通过加拿大小儿外科学网络(CAPSNet)和加拿大新生儿网络(CNN)对患有单纯性先天性腹壁裂的婴儿进行了回顾性研究。主要结局是达到完全肠内喂养的时间。
我们确定了 2014 年至 2022 年期间在 CAPSNet 中心治疗的 411 名先天性腹壁裂患儿。由于胎龄<32 周、出生体重<1500g、其他先天性异常或复杂的先天性腹壁裂,144 名患儿被排除在外。在其余 267 名参与者中,78%(n=209)在生命的头 28 天接受纯母乳喂养,而 22%(n=58)接受补充或纯配方奶。接受纯母乳喂养的婴儿达到完全肠内喂养的时间更长(中位数 24 天 vs 22 天,p=0.047),但更有可能延迟腹部闭合(32% vs 17%,p=0.03)。调整后,两组在达到完全肠内喂养的时间、肠外营养持续时间或住院时间方面无显著差异。接受补充或纯配方奶的婴儿患坏死性小肠结肠炎的风险相似(4% vs 3%),但出院时转为纯母乳喂养的可能性较小(73% vs 11%,p<0.001)。
在患有单纯性先天性腹壁裂的婴儿中早期使用纯母乳喂养与补充或纯配方奶相比具有相似的结局。接受补充或纯配方奶的患儿出院时不太可能转为纯母乳喂养。
IIb 级(个体队列研究)。